Compare · OPRX vs RELX
OPRX vs RELX
Side-by-side comparison of OptimizeRx Corporation (OPRX) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPRX and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $67.14B, about 402.8x OPRX ($166.7M).
- OPRX has been more active in the news (2 items in the past 4 weeks vs 1 for RELX).
- RELX has more recent analyst coverage (13 ratings vs 12 for OPRX).
- Company
- OptimizeRx Corporation
- RELX PLC PLC
- Price
- -
- -
- Market cap
- $166.7M
- $67.14B
- 1M return
- -
- +13.60%
- 1Y return
- -
- -15.27%
- Industry
- Real Estate
- Real Estate
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 2
- 1
- Recent ratings
- 12
- 13
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest OPRX
- Chief Business Officer D'Silva Andrew J. covered exercise/tax liability with 414 shares, decreasing direct ownership by 0.42% to 99,246 units (SEC Form 4) (withholding obligation)
- B. Riley Securities resumed coverage on OptimizeRx with a new price target
- OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
- OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
- OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
- Chief Business Officer D'Silva Andrew J. covered exercise/tax liability with 1,432 shares, decreasing direct ownership by 1% to 99,660 units (SEC Form 4) (withholding obligation)
- OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
- Chief Executive Officer Silvestro Stephen L was granted 79,200 shares, increasing direct ownership by 43% to 262,751 units (SEC Form 4)
- Chief Business Officer D'Silva Andrew J. was granted 57,600 shares, increasing direct ownership by 132% to 101,092 units (SEC Form 4)
- Chief Legal & Admin Officer Odence-Ford Marion was granted 57,600 shares, increasing direct ownership by 64% to 148,007 units (SEC Form 4)
Latest RELX
- SEC Form 6-K filed by RELX PLC PLC
- LexisNexis Risk Solutions Study Finds SNAP Fraud Costs Have Reached a Five-Year High
- TD Cowen initiated coverage on RELX
- Brightmine Extends Trusted Compliance Intelligence into Products and Services as AI Raises the Stakes for HR Decisions
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC